Five Prime Therapeutics Inc. (FPRX)

17.68 +0.37 (+2.137%)

IEX Real-Time Price

June 20, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 17.31

Price Open 17.37

Volume: 316,290

Avg Volume: 420,482

Market Cap: 622.5M

P/E Ratio -3.69

52 Wk Range 15.66-48.87



FPRX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-05-31
34.01M
2.81M
6.01
8.25%

2018-05-15
34.01M
3.69M
8.46
10.86%

2018-04-30
34.01M
3.48M
8.10
10.22%

2018-04-13
33.91M
3.62M
6.62
10.66%




FPRX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-08
Q1 2018
AMC
-0.54 (3)
-0.63
-0.09

2018-05-03
Q1 2018
N/A
-0.54 (3)
0.00
0.00

2018-02-27
Q4 2017
AMC
-1.29 (4)
-1.04
0.25

2018-02-22
Q4 2017
N/A
-1.29 (4)
-1.04
0.25

News

A High-Throughput Screen For Cancer Stocks That Have Few (Or No) Fundamentals (2018-06-16 09:00 SeekingAlpha)

Author's note: This article was presented early to subscribers of the Total Pharma Tracker , and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the way it captures the imagination and for…

 


Statistics

Shares Outstanding: 35.21M

Top 15 Institution Percent: 91.80

Price To Sales: 9.68

Price To Book: 1.65

Revenue: 16.16M

Gross Profit: N/A

Cash: 671.48M

Debt: N/A

Return On Assets: -30.14

Return On Equity: -35.38

Profit Margin: N/A

Price History

Beta: 3.41

50-day Moving Avg: 17.48

200-day Moving Avg: 24.58

YTD Change: -23.03

5-day Change: 0.23

1-month Change: -7.28

3-month Change: 5.23

6-month Change: -17.41

1-year Change: -40.04

Revenue Per Share: 0.00

Revenue Per Employee: 74792.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Five Prime Therapeutics Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.fiveprime.com

Five Prime Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel protein therapeutics to improve lives of patients with serious diseases.